2005
DOI: 10.1167/iovs.04-1172
|View full text |Cite
|
Sign up to set email alerts
|

Flt-1 Intraceptors Inhibit Hypoxia-Induced VEGF Expression In Vitro and Corneal Neovascularization In Vivo

Abstract: Flt-1 intraceptors, which are endoplasmic reticulum retention signal-coupled VEGF receptors, significantly suppress hypoxia-induced VEGF secretion by corneal epithelial cells in vitro. In vivo, delivery of naked plasmids expressing these intraceptors inhibits injury-induced upregulation of VEGF, leukocyte infiltration, and corneal neovascularization.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
48
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 66 publications
(50 citation statements)
references
References 38 publications
2
48
0
Order By: Relevance
“…Cancer cells acquire genetic and adaptive changes allowing them to survive and proliferate in a hypoxic microenvironment. In the cornea, hypoxia leads to pathological conditions in the cornea, such as neovascularization, re-epithelialization attenuation, and apoptosis (1)(2)(3)(4)(5). Hypoxia-induced cellular responses include activation of signaling events and gene expression that control important cellular function affecting cell cycle progression and apoptosis.…”
mentioning
confidence: 99%
“…Cancer cells acquire genetic and adaptive changes allowing them to survive and proliferate in a hypoxic microenvironment. In the cornea, hypoxia leads to pathological conditions in the cornea, such as neovascularization, re-epithelialization attenuation, and apoptosis (1)(2)(3)(4)(5). Hypoxia-induced cellular responses include activation of signaling events and gene expression that control important cellular function affecting cell cycle progression and apoptosis.…”
mentioning
confidence: 99%
“…Targeting angiogenesis with adenovirally delivered inhibitors of VEGF production might also be used as a treatment of angiogenesis-related diseases in the cornea. The angiogenic process has been shown to be driven by increased secretion of VEGF [23,24,25]. …”
Section: Discussionmentioning
confidence: 99%
“…89 Adenovirus-mediated transduction of corneal ECs with soluble VEGFR-1 successfully inhibited corneal neovascularisation in a rodent model. 90 The same group also used adenoassociated virus to reduce the development of 92 This group was also able to show viability gene transfer for the same receptor using a non-viral vector. 93 Another non-viral method employed experimentally for corneal antiangiogenic gene therapy was electroporation.…”
Section: Future Therapies May Rely On Local Gene Therapy To Influencementioning
confidence: 99%